{
  "title": "Peptide legal status by country",
  "publisher": "Peptlas Research Team",
  "url": "https://peptlas.com/peptide-status-by-country/",
  "license": {
    "name": "CC BY 4.0",
    "url": "https://creativecommons.org/licenses/by/4.0/"
  },
  "attribution": "Peptlas (https://peptlas.com/peptide-status-by-country/)",
  "last_verified": "2026-09-22",
  "jurisdictions": [
    {
      "authority": "United States (FDA)",
      "regulator": "FDA"
    },
    {
      "authority": "Australia (TGA)",
      "regulator": "TGA"
    },
    {
      "authority": "United Kingdom (MHRA)",
      "regulator": "MHRA"
    },
    {
      "authority": "European Union (EMA)",
      "regulator": "EMA"
    },
    {
      "authority": "Canada (Health Canada)",
      "regulator": "Health Canada"
    },
    {
      "authority": "Sport / anti-doping (WADA)",
      "regulator": "WADA"
    }
  ],
  "statuses": {
    "compounding_legal": {
      "label": "Compounding-legal",
      "meaning": "On the FDA 503A bulk-substances list; a licensed pharmacy may compound it. This is not the same as being an FDA-approved drug."
    },
    "under_review": {
      "label": "Under review",
      "meaning": "Actively before the FDA advisory committee; a decision is pending and the status can move."
    },
    "in_limbo": {
      "label": "In limbo",
      "meaning": "Moved on paper - nominated, removed from a restricted list, or recommended by an FDA committee - but not added to the 503A list. The headline implies a change; the legal status has not moved."
    },
    "restricted": {
      "label": "Restricted",
      "meaning": "Prescription-only, banned, controlled, or under active FDA enforcement."
    },
    "unscheduled": {
      "label": "Unscheduled",
      "meaning": "No specific federal action; unaddressed at this time."
    }
  },
  "rows": [
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 23, 2026 (8-6, 1 abstention); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Reported as Schedule 4 (prescription-only) under the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not an authorized drug; Health Canada's April 2026 advisory names BPC-157 among unauthorized injectable peptides and states such products are illegal to sell in Canada.",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "BPC-157",
      "slug": "bpc-157",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times under category S0 (non-approved substances). Unchanged on the 2027 List (published Sep 21, 2026; in force Jan 1, 2027).",
      "entry_url": "https://peptlas.com/entries/bpc-157/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Investigational; not approved, not compoundable (not a component of an approved drug, not an eligible bulk substance). The CagriSema NDA is under FDA review; warning letters to sellers, including products sold under coded names.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named or scheduled in the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; not on EMA's August 2026 list of applications under CHMP evaluation; sale as a medicine unlawful EU-wide, with enforcement at member-state level.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "under_review",
      "status_label": "Under review",
      "note": "Cagrilintide/semaglutide new drug submission (Novo Nordisk) accepted into Health Canada review in March 2026; no cagrilintide product yet authorized in the Drug Product Database.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Cagrilintide",
      "slug": "cagrilintide",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times, but not listed by name - captured by the S0 catch-all for substances with no regulatory approval for human use.",
      "entry_url": "https://peptlas.com/entries/cagrilintide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Removed from Category 2 (~Sept 2024); PCAC voted against inclusion Dec 4, 2024; not on the 503A list; no USP monograph.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Reported as Schedule 4 (prescription-only) under the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; absent from the Union Register, so sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized by Health Canada; named in an April 2026 public advisory on unauthorized injectable peptides, which states such products are illegal to sell and reports seizures.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "CJC-1295",
      "slug": "cjc-1295",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times under S2 as a growth-hormone-releasing factor analogue.",
      "entry_url": "https://peptlas.com/entries/cjc-1295/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC voted against adding it on Jul 24, 2026 (6-7, 1 abstention). No further FDA action is scheduled.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation for emideltide (DSIP); sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized in Canada; Health Canada's April 2026 advisory names DSIP among unauthorized injectable peptide drugs that are illegal to sell.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Emideltide (DSIP)",
      "slug": "emideltide",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not individually named, but prohibited at all times under the S0 catch-all for non-approved substances.",
      "entry_url": "https://peptlas.com/entries/emideltide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 24, 2026 (7-4, 1 abstention); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Named in Health Canada's April 2026 advisory on unauthorized injectable peptides; absent from the Drug Product Database, so sale for human use is illegal under the Food and Drugs Act.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Epitalon",
      "slug": "epitalon",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not individually named, but prohibited at all times under the S0 catch-all for non-approved substances.",
      "entry_url": "https://peptlas.com/entries/epitalon/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Topical route ≈ Category 1; injectable route removed from Category 2, not on the 503A list; PCAC review expected before end of Feb 2027.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; topical cosmetic products are freely available.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply as a medicine is unlicensed, though copper tripeptide-1 remains a permitted cosmetic ingredient under GB cosmetics law.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not in the Drug Product Database; Health Canada recalled GHK-Cu powder as an unauthorized active pharmaceutical ingredient in May 2026.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "GHK-Cu",
      "slug": "ghk-cu",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not explicitly named on the Prohibited List.",
      "entry_url": "https://peptlas.com/entries/ghk-cu/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Removed from Category 2 (~Sept 2024); PCAC voted against 503A inclusion Oct 29, 2024; not on any bulks list; no separate ban.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Reported as Schedule 4 (prescription-only) under the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; absent from the Union Register, so sale as a medicine is unlawful EU-wide, with enforcement at member-state level.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized for sale; Health Canada's April 2026 advisory names ipamorelin as an unauthorized injectable peptide drug that is illegal to sell in Canada.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Ipamorelin",
      "slug": "ipamorelin",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times under S2 as a growth-hormone secretagogue.",
      "entry_url": "https://peptlas.com/entries/ipamorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 23, 2026 (8-6, 1 abstention); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; not found in EMA's centralised medicines database, so sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized for sale; listed in an April 2026 Health Canada advisory among unauthorized injectable peptide drugs it has seized, with peptides generally regulated as prescription drugs in Canada.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "KPV",
      "slug": "kpv",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not individually named, but prohibited at all times under the S0 catch-all for non-approved substances.",
      "entry_url": "https://peptlas.com/entries/kpv/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on Category 1 / the 503A list; being moved out of Category 2; PCAC review expected before end of Feb 2027. Not DEA-scheduled.",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Schedule 4 (prescription-only); no products registered on the ARTG; TGA has issued infringement notices for unlawful supply.",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; MHRA has repeatedly removed melanotan products from sale for over 10 years, though nasal sprays without medicinal claims are not generally regulated as medicines.",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation - no melanotan II entry in EMA's centrally authorised medicines database; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized for sale; Health Canada names Melanotan I and II among unauthorized injectable peptide drugs it has seized, warning that unauthorized drug products are illegal in Canada.",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Melanotan II",
      "slug": "melanotan-2",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times, but not listed by name - captured by the S0 catch-all for non-approved substances (also argued under S2).",
      "entry_url": "https://peptlas.com/entries/melanotan-2/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 23, 2026 (7-5, 2 abstentions); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides.",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation in the Union Register; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Named in Health Canada's April 2026 advisory on unauthorized injectable peptides; unauthorized drug products are illegal to sell in Canada.",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "MOTS-c",
      "slug": "mots-c",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Explicitly named on the 2026 Prohibited List under S4.4.1 (metabolic modulators / AMPK activators); prohibited at all times. Still listed on the 2027 List (published Sep 21, 2026; in force Jan 1, 2027).",
      "entry_url": "https://peptlas.com/entries/mots-c/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Proposed for non-inclusion (2019); no final rule and no ban; oral sold as a supplement; injectable compounded in a gray area.",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Per an April 2025 TGA safety alert, NAD/NAD+/NADH are not permitted ingredients in listed medicines.",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; injectable NAD+ is supplied only as an unlicensed 'special' on a prescriber's order, while oral NAD+ is sold under food-supplement rules.",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; injectable NAD+ cannot be marketed as a medicine EU-wide, with enforcement handled at member-state level; oral NAD+ circulates under food-supplement law.",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No approved injectable NAD+ in the Drug Product Database; an April 2026 Health Canada advisory lists NAD+ among unauthorized injectable drugs illegal to sell; oral NAD+ is regulated as a natural health product.",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "NAD+",
      "slug": "nad-plus",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not named on the Prohibited List, but IV infusions over 100 mL per 12 hours are prohibited as a method (M2.2).",
      "entry_url": "https://peptlas.com/entries/nad-plus/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Investigational; not approved, not compoundable (never on the shortage list, not an eligible bulk substance). FDA warning letters to sellers, including products sold under coded names.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not in the ARTG; the TGA names retatrutide among unapproved peptide products and takes enforcement action against unlawful import, compounding, supply and advertising.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine - MHRA has seized unlicensed retatrutide products in enforcement operations.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation and no application under CHMP evaluation as of August 2026; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized by Health Canada; named in an April 2026 advisory on unauthorized injectable peptide drugs - unauthorized drug products are illegal to sell in Canada.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Retatrutide",
      "slug": "retatrutide",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times, but not listed by name - captured by the S0 catch-all for substances with no regulatory approval for human use.",
      "entry_url": "https://peptlas.com/entries/retatrutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Removed from Category 2 (~Sept 2024); never in Category 1; not on the 503A list; no scheduled PCAC review.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named or scheduled in the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; Selank does not appear in the Union Register, so sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized by Health Canada; a 2025 public advisory named Selank among seized unauthorized injectable peptide drugs, stating that selling unauthorized drugs is illegal in Canada.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Selank",
      "slug": "selank",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Falls under S0 (non-approved substances); prohibited at all times for tested athletes.",
      "entry_url": "https://peptlas.com/entries/selank/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Enforcement discretion ended Apr 22, 2025 (503A) / May 22, 2025 (503B); FDA proposed permanent 503B exclusion (Apr 2026). Narrow patient-specific 503A exception remains.",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "GLP-1 analogues removed from the pharmacist compounding exemption effective Oct 1, 2024; remains Schedule 4.",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Licensed prescription-only medicine; unlicensed copies may not be supplied where the licensed product can meet the patient's need, and MHRA enforces against unlicensed semaglutide products.",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Centrally authorised prescription-only medicine; compounded versions hold no EU marketing authorisation, with enforcement against unlicensed supply handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Authorized prescription-only medicine (Ozempic, Wegovy); compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada has recalled compounded semaglutide made with an unauthorized API.",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semaglutide",
      "slug": "semaglutide",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not prohibited; on the WADA Monitoring Program since 2024. WADA confirmed GLP-1 status is unchanged for 2027 (Sep 21, 2026).",
      "entry_url": "https://peptlas.com/entries/semaglutide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 24, 2026 (8-5, 1 abstention); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not individually named in the Poisons Standard; sits in a grey area.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No Health Canada authorization; named in an August 2025 Health Canada seizure advisory on unauthorized injectable peptides, which cannot legally be sold in Canada.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Semax",
      "slug": "semax",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not individually named, but prohibited at all times under the S0 catch-all for non-approved substances.",
      "entry_url": "https://peptlas.com/entries/semax/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "compounding_legal",
      "status_label": "Compounding-legal",
      "note": "Category 1 of the interim 503A list; compoundable with a valid prescription under enforcement discretion. Previously approved as Geref.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prescription-only (Schedule 4) as a GHRH analog; obtainable via compounding pharmacy on prescription.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No centralised EU marketing authorisation (absent from the Union Register); sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Named on the Prescription Drug List ('Sermorelin or its salts', effective 2013-12-19); no product currently authorized in the Drug Product Database.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Sermorelin",
      "slug": "sermorelin",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "GHRH analogs fall under S2; prohibited at all times.",
      "entry_url": "https://peptlas.com/entries/sermorelin/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Not on the 503A Bulks List. PCAC recommended adding it on Jul 23, 2026 (8-6, 1 abstention); the recommendation is advisory and the FDA has not acted.",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Thymosin beta-4 treated as Schedule 4 (prescription-only) under the Poisons Standard.",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU marketing authorisation; sale as a medicine is unlawful EU-wide, with enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized for sale; Health Canada has seized TB-500 among unauthorized injectable peptides and states selling unauthorized drugs is illegal in Canada.",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "TB-500 (Thymosin Beta-4)",
      "slug": "tb-500",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Prohibited at all times as a growth factor / non-approved substance. Unchanged on the 2027 List (published Sep 21, 2026; in force Jan 1, 2027).",
      "entry_url": "https://peptlas.com/entries/tb-500/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "in_limbo",
      "status_label": "In limbo",
      "note": "Removed from Category 2 (Sept 2024); PCAC declined to recommend it on Dec 4, 2024; not on the 503A list; no approved U.S. product.",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Regulated as Schedule 4 (prescription-only); the TGA has enforced against unlawful advertising.",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No UK marketing authorisation; supply for human use treated as an unlicensed medicine.",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "No EU-wide EMA marketing authorisation - thymalfasin holds only an orphan designation (EU/3/02/110) - and is reported as nationally authorised on prescription in Italy as Zadaxin.",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Not authorized for sale; no Drug Product Database listing, and Health Canada named thymosin alpha-1 among unauthorized injectable peptides seized in April 2025.",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Thymosin Alpha-1",
      "slug": "thymosin-alpha-1",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not specifically named on the Prohibited List (distinct from thymosin beta-4, which is prohibited).",
      "entry_url": "https://peptlas.com/entries/thymosin-alpha-1/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "United States (FDA)",
      "regulator": "FDA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Enforcement discretion ended Feb 18, 2025 (503A) / Mar 19, 2025 (503B); FDA proposed permanent 503B exclusion (Apr 2026). Narrow 503A exception remains.",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "Australia (TGA)",
      "regulator": "TGA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "GLP-1 compounding prohibited since Oct 1, 2024; remains Schedule 4.",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "United Kingdom (MHRA)",
      "regulator": "MHRA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Licensed prescription-only medicine; no legitimate compounding pathway; MHRA enforces against unlicensed product.",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "European Union (EMA)",
      "regulator": "EMA",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Licensed prescription-only medicine EU-wide (Mounjaro, authorised 2022); unauthorised versions cannot be marketed, with pharmacy compounding exemptions and enforcement handled at member-state level.",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "Canada (Health Canada)",
      "regulator": "Health Canada",
      "status": "restricted",
      "status_label": "Restricted",
      "note": "Authorized prescription-only medicine (Mounjaro); compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada warns selling unauthorized versions is illegal in Canada.",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    },
    {
      "compound": "Tirzepatide",
      "slug": "tirzepatide",
      "jurisdiction": "Sport / anti-doping (WADA)",
      "regulator": "WADA",
      "status": "unscheduled",
      "status_label": "Unscheduled",
      "note": "Not prohibited; added to the WADA Monitoring Program effective Jan 1, 2026. WADA confirmed GLP-1 status is unchanged for 2027 (Sep 21, 2026).",
      "entry_url": "https://peptlas.com/entries/tirzepatide/",
      "last_verified": "2026-09-22"
    }
  ]
}